Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03447314
Title Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline

head and neck squamous cell carcinoma

Advanced Solid Tumor


GSK1795091 + GSK3174998


Age Groups: senior | adult
Covered Countries USA | ESP | CAN

No variant requirements are available.